HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders.

Abstract
N-propargyl-1-(R)aminoindan (rasagiline) is a new and selective irreversible MAO-B inhibitor, currently being considered as the mesylate salt for potential therapy in certain neurological disorders. It has been studied in animal models of cognition and motor dysfunction. Its ability to restore normal motor activity was determined in models of acute drug-induced dopaminergic dysfunction: Its effects in improving cognition and memory deficits was studied in adult and senescent rats that had been exposed to prolonged hypoxia, then subjected to the passive and active avoidance tests. In alpha-methyl-p-tyrosine (alpha-MpT)-induced hypokinesia (100-120 mg/kg, i.p.) pretreatment with rasagiline at 2.5 mg/kg i.p. restored motor activity to control level. But pretreatment with reserpine abolished the protective effect of rasagiline. Rasagiline at 0.5 mg/kg/day was protective against alpha-MpT also in hypoxia-lesioned rats. In haloperidol-induced catalepsy in rats (1.5 mg/kg, s.c.) or mice (4-6 mg/kg s.c.), rasagiline improved recovery of normal locomotion, gait and coordination at 0.4-2.4 mg/kg i.p. and 1.8-1.5 mg/kg i.p., respectively. In amphetamine-induced stereotypy (0.6 mg/kg s.c., rasagiline potentiated this effect at 1.5 mg/kg i.p. In hypoxia-induced impairment of memory and learning, rasagiline at 0.32-0.5 mg/kg/day per os improved performance of adult rats in passive and active avoidance, and of senescent rats in active avoidance. Selegiline was either ineffective or less effective at equivalent doses. Racemic N-propargyl-1-aminoindan (AGN-1135), besides being of lower potency, had a different dose-dependency than rasagiline in antagonizing haloperidol-induced catalepsy or alpha-MpT-induced hypokinesia. 1-(R)aminoindan ((R)AI), a metabolite of rasagiline, in relatively high doses produced effects that were distinct in certain respects from those of rasagiline.
AuthorsZ Speiser, R Levy, S Cohen
JournalJournal of neural transmission. Supplementum (J Neural Transm Suppl) Vol. 52 Pg. 287-300 ( 1998) ISSN: 0303-6995 [Print] Austria
PMID9564629 (Publication Type: Journal Article)
Chemical References
  • Indans
  • Monoamine Oxidase Inhibitors
  • rasagiline
  • alpha-Methyltyrosine
  • Haloperidol
Topics
  • Aging
  • Animals
  • Avoidance Learning (drug effects, physiology)
  • Catalepsy (chemically induced, prevention & control)
  • Cognition (drug effects, physiology)
  • Cognition Disorders (drug therapy)
  • Haloperidol (toxicity)
  • Hypokinesia (chemically induced, physiopathology, prevention & control)
  • Hypoxia
  • Indans (pharmacology)
  • Male
  • Memory (drug effects, physiology)
  • Mice
  • Mice, Inbred ICR
  • Monoamine Oxidase Inhibitors (pharmacology)
  • Motor Activity (drug effects)
  • Rats
  • Rats, Wistar
  • alpha-Methyltyrosine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: